Show simple item record

dc.contributor.authorAmerican Legion. National Executive Committee
dc.date.accessioned2018-10-18T19:25:47Z
dc.date.available2018-10-18T19:25:47Z
dc.date.issued2018-10
dc.identifier.other2018f017
dc.identifier.urihttps://hdl.handle.net/20.500.12203/9914
dc.descriptionOrigin: Resolution No. 97 (Washington) 2018 National Convention; Submitted by: Veterans Affairs & Rehabilitation Commission
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.subject2018 Fall Meeting of the National Executive Committee
dc.subjectVeterans Affairs & Rehabilitation
dc.titleResolution No. 17: Encouraging VA to Conduct Research on the Effects of Anti-Malarial Drug Mefloquine for a Suspected Link to Mental Health Disabilities
dc.typeResolution
dc.rights.holderAmerican Legion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record